Proteomics International Laboratories Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.132x

Proteomics International Laboratories Ltd cash flow conversion efficiency. Based on the latest financial reports, Proteomics International Laboratories Ltd (PIQ) has a cash flow conversion efficiency ratio of -0.132x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-950.22K ≈ $-672.34K USD) by net assets (AU$7.21 Million ≈ $5.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Proteomics International Laboratories Ltd (2014–2025)

Cash flow conversion efficiency of Proteomics International Laboratories Ltd from 2014 to 2025. This chart illustrates how Proteomics International Laboratories Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PIQ live share price for real-time trading data and today's change.

Proteomics International Laboratories Ltd Cash Flow Conversion Ratio Explained

Proteomics International Laboratories Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Proteomics International Laboratories Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Proteomics International Laboratories Ltd ranked by their cash flow conversion efficiency. Also see market value of Proteomics International Laboratories Lt for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Energisme PA:ALNRG	-1.376x
Hookipa Pharma Inc NASDAQ:HOOK	-0.249x
Femasys Inc NASDAQ:FEMY	-0.976x
Baillie Gifford US Growth Trust PLC LSE:USA	-0.004x
Prodigy Gold NL AU:PRX	-0.311x
Oncosil Medical Ltd AU:OSL	-1.814x
IRIDEX Corporation NASDAQ:IRIX	0.048x
Goodyear Lastikleri TAS IS:GOODY	0.150x

Annual Cash Flow Conversion Efficiency for Proteomics International Laboratories Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Proteomics International Laboratories Ltd from 2014 to 2025. Review Proteomics International Laboratories Lt free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$12.97 Million ≈ $9.18 Million	AU$-6.60 Million ≈ $-4.67 Million	-0.509x	+15.78%
2024-06-30	AU$9.25 Million ≈ $6.54 Million	AU$-5.59 Million ≈ $-3.96 Million	-0.605x	+11.59%
2023-06-30	AU$8.32 Million ≈ $5.89 Million	AU$-5.69 Million ≈ $-4.03 Million	-0.684x	+34.43%
2022-06-30	AU$3.39 Million ≈ $2.40 Million	AU$-3.54 Million ≈ $-2.50 Million	-1.043x	-259.29%
2021-06-30	AU$7.61 Million ≈ $5.38 Million	AU$-2.21 Million ≈ $-1.56 Million	-0.290x	-235.07%
2020-06-30	AU$4.44 Million ≈ $3.14 Million	AU$-384.51K ≈ $-272.06K	-0.087x	+84.48%
2019-06-30	AU$2.99 Million ≈ $2.11 Million	AU$-1.67 Million ≈ $-1.18 Million	-0.558x	-140.84%
2018-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-1.08 Million ≈ $-766.91K	-0.232x	+74.63%
2017-06-30	AU$1.61 Million ≈ $1.14 Million	AU$-1.47 Million ≈ $-1.04 Million	-0.914x	+52.09%
2016-06-30	AU$791.42K ≈ $559.98K	AU$-1.51 Million ≈ $-1.07 Million	-1.907x	-408.33%
2015-06-30	AU$1.81 Million ≈ $1.28 Million	AU$-677.26K ≈ $-479.21K	-0.375x	-469.06%
2014-06-30	AU$4.94 Million ≈ $3.50 Million	AU$-325.72K ≈ $-230.47K	-0.066x	--

About Proteomics International Laboratories Ltd

AU:PIQ Australia Biotechnology

Market Cap

$11.45 Million

AU$16.19 Million AUD

Market Cap Rank

#26550 Global

#1199 in Australia

Share Price

AU$0.10

Change (1 day)

-2.00%

52-Week Range

AU$0.09 - AU$0.84

All Time High

AU$1.35